arrow
T

Tae Won Jang

hanyang university
H指数:25
被引数:2,222

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Population pharmacokinetics of levofloxacin in drug-susceptible and drug-resistant tuberculosis patients: Optimal dose suggestion based on renal function

左氧氟沙星在药物敏感性和药物耐药性结核病患者中的群体药代动力学:基于肾功能的最优剂量建议

2025-07-230
PREAI
Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data

真实世界一线阿法替尼治疗晚期EGFR突变阳性非小细胞肺癌: 更新的生存数据

2023-11-010
OAAI
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors

EGFR突变非小细胞肺癌脑转移患者一线阿法替尼的真实世界分析: 生存和预后因素

2023-06-012
OAAI
Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea

韩国阿法替尼一线治疗晚期EGFR突变阳性非小细胞肺癌的真实经验

2021-12-0111
OAAI